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Abstract
Background: Rates of aggression in inpatient secure care are higher than in other psychiatric inpatient settings.
People with intellectual disabilities in secure care require adapted psychological treatments. Interpersonal art
psychotherapy incorporates the use of creative art making approaches by participants, thus reducing sole reliance
upon verbal interactions during psychotherapy for people who may have communication difficulties. During
interpersonal art psychotherapy, participants are individually supported by their therapist to consider how they
conduct relationships. This includes the influence and impact of interpersonal issues resulting in repeated patterns
of conflict. The key feasibility objectives were to assess recruitment and retention rates, follow-up rates and trial
procedures such as randomisation, allocation and identifying any practical or ethical problems. In addition, a
preliminary ‘signal’ for the intervention was considered and an indicative sample size calculation completed. The
acceptability of a potential third trial arm attentional control condition, mindful colouring-in, was assessed using four
single-case design studies and a UK trial capacity survey was conducted.
Methods: Adult patients with intellectual disabilities in secure care were recruited and randomised to either
interpersonal art psychotherapy or delayed treatment in this multi-site study. Outcomes were assessed using weekly
observations via the Modified Overt Aggression Scale and a range of self-report measures. Within study reporting
processes, qualitative interviews and a survey were completed to inform trial feasibility.
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Results: Recruitment procedures were successful. The target of recruiting 20 participants to the trial from multiple sites
was achieved within 8 months of the study opening. All participants recruited to the treatment arm completed
interpersonal art psychotherapy. Between-group differences of interpersonal art psychotherapy versus the delayed
treatment control showed a ‘signal’ effect-size of .65 for total scores and .93 in the verbal aggression sub-scale. There
were no amendments to the published protocol. The assessment of key feasibility objectives were met and the trial
procedures were acceptable to all involved in the research.
Conclusion: This study suggested that a randomised controlled trial of interpersonal art psychotherapy is acceptable
and feasible.
Trial registration: ISRCTN14326119 (Retrospectively Registered).
Key messages
1) What uncertainties existed regarding the feasibility?
 Recruitment, retention and follow-up rates.
 Trial procedures.
 Indicative sample size and capacity for a RCT in
secure care.
2) What are the key feasibility findings?
 Recruitment, retention and follow-up rates were
acceptable.
 Trial procedures were viable with requirements
for minor adjustment only.
 A randomised controlled trial of interpersonal
art psychotherapy is acceptable and feasible.
3) What are the implications of the feasibility findings
for the design of the main study?
 The reduction of aggression is a primary
outcome.
 An attentional condition could be included as a
potential third arm in a future trial.
 Within-trial cost-effectiveness analysis can be
conducted.
Background
Within England, estimates suggest 3035 (0.3%) of people
who have an intellectual disability are receiving treat-
ment in psychiatric hospital settings’ with half being
treated in inpatient secure care settings’ [1]. The pres-
ence of a co-occurring mental illness can significantly
increase the likelihood of people with intellectual disabil-
ities having experienced victimisation and/or committing
offences [2]. Secure care, including within the NHS, pro-
vides treatment for adults with mental illness, personal-
ity disorder and neurodevelopmental disorders including
intellectual disability and autism [3]. Patients with intel-
lectual disability being treated in secure care wards are
more likely to have a long stay in hospital, defined as
more than 10 years in high secure, 5 years in medium
secure or 15 years in a mix of high and medium secure
settings, compared to patients in other types of secure
mental health wards [4]. The health expenditure for
adults with intellectual disability in secure care is
estimated to be over 300 million pounds sterling per
annum [1].
A systematic meta-analysis of violence in psychiatric
settings (23,972 patients) reported that the proportion of
patients who committed at least one act of violence was
17% (95% confidence interval (CI) 14–20%) [5]. Factors
associated with higher rates of violence and aggression
in inpatient psychiatric settings include there being a
higher proportion of male patients; involuntary patients;
patients with a diagnosis of schizophrenia; and patients
with alcohol use disorder [5]. In community residential
settings, factors associated with aggression are similar
and include lifetime substance and alcohol misuse, a his-
tory of violence and patients having a diagnosis of a per-
sonality disorder [6]. Previous studies have reported
patients in secure care/forensic as being more likely to
be violent than those in other types of psychiatric units
[7]. People with intellectual disability who are inpatients
in services and/or residential care are more likely to have
reported aggression compared with people living inde-
pendently [8]. Studies of individuals with moderate intel-
lectual disability who live in a residential facility have
shown that in most cases, aggressive behaviour was posi-
tively or negatively reinforced by social and task-related
events [9, 10]. Interpersonal perceptions and dynamic
relational factors have been identified as having a role in
determining staff responses [11]. Greater sensitivity in
interpersonal situations has been identified as contribut-
ing to the likelihood of aggression in some people with
intellectual disabilities [12, 13]. Problems of aggression
might partly be exacerbated by a tendency towards per-
ceiving hostility in others, heightened emotional arousal
and personal experiences of conflict [14–16].
A systematic review (2019) of randomised controlled
trials (RCT) of psychological interventions offered to
forensic/secure mental health inpatients (n = 9 studies
including 523 participants) reported that current prac-
tice is based on limited evidence with no consistent sig-
nificant findings [17]. Study sample sizes ranged from 14
to 112. A low risk of bias assessment indicated that good
quality RCTs can be undertaken within inpatient
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medium to high secure forensic settings. Economic eval-
uations were not included in the studies. The review
concluded that further studies are needed to clarify the
evidence base [17].
The most recent summary of research with offenders
who have intellectual disability (2018) identified the de-
velopment of effective interventions for this vulnerable
group as a priority [18]. Adaptations are required for
psychological interventions for people who have intellec-
tual disabilities and mental health problems [19] with
specific recommendations for adult patients in secure
care [3].
National practice-based guidelines have been devel-
oped for art therapy with people who have an intellec-
tual disability [20] as an approach that places less of a
burden on verbal communication within psychotherapy.
A systematic review of the clinical effectiveness of art
therapy amongst people with non-psychotic mental
health disorders [21] identified 15 RCTs (n = 777), but
excluded people with intellectual disabilities. Improve-
ments to the design of future art therapy trials were con-
sidered to be the inclusion of non-active treatment as
usual/wait-list control arm, attentional (art and craft ac-
tivity) control and/or an active psychological comparator
[21]. The report concluded that art therapy showed posi-
tive effects and an indication of cost-effectiveness com-
pared to wait-list control [21]. Interpersonal art
psychotherapy has been developed for use with adults
who have mild/moderate intellectual disability in secure
care [22–26].
Aims
1. To test the feasibility of conducting an RCT
evaluating interpersonal art psychotherapy in NHS
secure care, identifying:
 Recruitment and retention rates
 Follow-up rates
 Trial procedures (randomisation and allocation
to delayed treatment waiting-list, measurement
and fidelity) generating any practical or ethical
problems
2. To obtain a preliminary ‘signal’ for the intervention
and indicative sample size calculation.
3. To assess the acceptability of a potential third trial
arm attentional control condition, mindful
colouring-in.
4. To survey NHS secure care sites to assess capacity
for a future definitive trial.
Methods
All procedures in this study received NHS ethical ap-
proval from the Health Research Authority (IRAS pro-
ject ID: 191223, REC reference: 16/NE/0220). The full
study protocol was published in an open access journal
in October 2017 [26]. Informed consent was obtained




This was a multi-site, 1:1 randomised controlled feasibil-
ity study, with participants being randomised to either
interpersonal art psychotherapy plus usual care or usual
care with delayed treatment (waiting-list).
Single-case design
To inform future trial design and the potential for inclu-
sion of an attentional control condition [27–29], four sep-
arate single-case design (SCD) studies were run in parallel
to the RCT. Mindful colouring-in was chosen and piloted
as a novel art-based attentional condition [30] followed by
an assessment of the acceptability of the intervention [31,
32]. An ‘ABACA’ design was used [33] A(1) = base-
line; B = mindful colouring-in; A(2) = monitoring; C
= interpersonal art psychotherapy; A(3) = post-
therapy. One-to-one semi-structured qualitative inter-
views were completed with participants and the find-
ings from thematic analysis [34] were mapped against
a treatment acceptability framework [32].
Survey
A survey of NHS secure care providers in the UK was
carried out to ascertain capacity and interest in par-
ticipation in a future trial.
Feasibility objectives
The feasibility objectives included:
1. Recruitment, such as patients’ willingness to be
randomised and clinicians’ willingness to recruit
their patients into the study; assessed by the
recruitment target being met for the number of
consented participants during enrolment (n = 20).
2. Identifying ethical issues related to seeking
informed consent and risks of coercion, including
the potential for patients to participate in the study
believing it will positively or negatively influence
their inpatient treatment or detention under the
Mental Health Act [35]; assessed during enrolment
from the number of patients agreeing and/or
declining to participate and the responses collected
from patients declining to participate after receiving
study participant information.
3. Suitability of procedures and materials, including
study information, outcome measures, burden of
outcome measures/validated tools, data collection
and maintenance of data integrity from multiple
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study sites; assessed by local research assistants
reporting feedback from participants at each data
collection point (baseline, post-, follow-up) on the
burden of outcome questionnaires. The level of
completion of questionnaires (instrument and item
response rates) was monitored and recorded within
routine data integrity checks.
4. Describing routine care/treatment as usual,
identifying characteristics of treatment as usual and
individualised patient care pathways across multiple
sites, within high and medium/low security;
assessed via an inventory of participant care plans
found within medical records. Checks were
conducted by research assistants at baseline for all
enrolled participants across multiple-sites.
5. Attrition and acceptability, including rates of
attendance for treatment, reasons for non-
attendance and/or drop-out and lack of retention
for data collection at the follow-up points; assessed
by study therapists recording participant attend-
ance/non-attendance to treatment sessions, re-
search assistants recording participant reasons for
drop-out (including those in the delayed treatment
wait-list arm), and rates of retention for follow-up
data collection.
6. Identifying risks of contamination, such as
participants on the waiting-list/delayed treatment
arm receiving active components of the treatment
during routine care; assessed at baseline by comple-
tion of an inventory of participant care plans carried
out by research assistants for all enrolled across
multiple-sites. An ongoing review of changes in
care provision for participants in the treatment arm
was completed by study therapists within 18 weeks
(concurrent with interpersonal art psychotherapy).
7. Treatment fidelity, identifying therapist adherence
with the required activity in the treatment manual
and piloting treatment fidelity measure; assessed by
measures of inter-rater reliability applied within
treatment fidelity checks, random selection and
treatment fidelity checklist assessment of audio
recordings of treatment sessions (n = 27 session
recordings), and post-study qualitative group inter-
views with all study therapists to capture their re-
sponses to delivering the manualised intervention.
8. Acceptability of a novel attentional condition;
assessed in four separate single-case design studies




Patients took part in the RCT from three secure hospi-
tals in England (Nottinghamshire, Lancashire, and East
London) from February 2017 with all data collection
completed by February 2019. The study aimed to recruit
10 participants to each arm (n = 20) with the study be-
ing focused upon assessing feasibility across multiple-
sites. Participant recruitment targets were met within 8
months of the study opening.
Eligibility
Secure care patients were eligible for inclusion if they
were an adult the age of 18 and over, an inpatient in a
NHS secure hospital, with an IQ of between 55 and 79
(within a range including moderate to mild intellectual
disability and borderline intellectual functioning), and
able to give informed consent [36]. The patient’s
involvement in the study required support from their
responsible clinician and/or multi-disciplinary team
(MDT). Patients were considered eligible if they had a
clinical profile that included a historic and/or continuing
presentation of emotional control difficulties and/or ob-
served aggression.
Patients were excluded if they were deemed unable to
give informed consent, had no clinical indicators for the
psychotherapeutic treatment in their clinical profile, had
a planned discharge from hospital within 12 months of
the start of the study or were undergoing medication
dose titration for the treatment of acute psychotic symp-
toms. The inclusion and exclusion criteria remained
unchanged throughout the study. Patient eligibility
checking was carried out by study therapists followed by




Interpersonal art psychotherapy has been developed as a
brief structured manualised psychological therapy for
people with mild to moderate intellectual disabilities
[22, 23, 25, 26]. It incorporates creative art approaches
to enhance engagement and aid understanding [20].
The interpersonal component of the treatment manual
is informed by the core conflictual relationship theme
(CCRT) approach, the CCRT being the central relation-
ship pattern, script, or schema that each person might
follow in conducting their relationships [23, 25]. The
therapy includes exploration of themes associated with
the participants’ own accounts of their interactions with
people [37].
Interpersonal art psychotherapy consisted of 15 individ-
ual weekly 1-h sessions provided by a UK Health and Care
Professions Council (HCPC) art therapist with experience
of working in secure care with people who have intellec-
tual disabilities. A therapist worked with one patient for
the duration of treatment with a target of completing all
of the therapy topics within an 18-week period. The
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therapy topic session schedule is as follows, sessions 1 to 3
personal goals, coping responses and self-management; 4
to 5 relationships; 6 to 10 life events; 11 to 12 interper-
sonal themes; 13 to 15 imagined future and final review.
The structure of each therapy session is as follows; the
therapist introduces the session content, agenda setting, a
directed art activity (as determined by the manual and ses-
sion schedule) and a reflective discussion about the art ac-
tivity. Therapists ‘augment’ reflective discussions by using
supplied resources or creating additional visual material to
aid communication and understanding.
Study therapists completed 2-days of training which
included familiarization with the manual, formal teach-
ing, group discussion and rehearsal/role-play. During the
study, individual clinical supervision was provided on a
fortnightly to monthly basis. For the purpose of com-
pleting treatment fidelity checks, audio recordings of
therapy sessions were reviewed by the research team
against a treatment fidelity measure. The interpersonal
art psychotherapy checklist was developed and piloted
separately by two raters resulting in agreement on four
criterion recordings (SH and AZ). Inter-rater discussion
and consensus rating led to further refinement of check-
list for inter-rater training purposes. Prior to full assess-
ment of treatment fidelity within the study, the checklist
(34 items in total, 29 items scoring on a three point cat-
egorical ordinal scale) was assessed against a sample of
recordings selected from different therapists, different
clients and different time points (2 early, 1 middle, 1 late
therapy). Inter-rater reliability testing was conducted by
two independent raters (AZ and TLH) with agreement
ranging from 72.1% at initial unguided rating to 88.3% at
second rating following inter-rater reflective training.
Both Kappa and weighted Kappa were calculated [38, 39]
with Kappa below 0.60 taken to indicate inadequate agree-
ment [40]. Kappa values were calculated from all inde-
pendently rated recordings at two stages of inter-rater
reliability testing. At initial unguided rating, mean Kappa
was 0.52 and weighted Kappa was 0.65, whilst at rating
following training, the mean values were 0.80 and 0.85
respectively.
Usual care (delayed treatment)
Usual care within inpatient secure settings involves as-
sessment and treatment by a specialist MDT using the
Care Programme Approach (CPA) [3] to coordinate and
plan care. MDTs comprise psychiatrists, clinical and
forensic psychologists, mental health and intellectual dis-
ability nursing staff and allied health professionals
(AHPs), for example, occupational therapists, arts thera-
pists and speech and language therapists. The work of
MDTs includes risk assessment/formulation and man-
agement, recovery focused care and/or positive behav-
iour support (PBS) [3]. Access to psychotherapy/psycho-
educational work includes anger management and anger
maintenance, emotions group, drug and alcohol work,
speech and language therapy and/or communication
group, art therapy group, relaxation, sex education and
specific offence related treatment, such as sex offender
treatment. Pharmacotherapy treatment and review in-
clude (where required) the prescription of mood stabili-
sers, antipsychotic medication, stimulant medication (for
the treatment of attention deficit hyperactivity disorder)
and rapid tranquilising medication, pro re nata (PRN).
An inventory of participants’ care plans (treatment as
usual) was completed. Assessment of care-coordination,
MDT members and the provision of bio-psycho-social
components of treatment [3] were shown to be present
and provided to participants across study sites. Two par-
ticipants in the delayed treatment waiting-list continued
to attend a weekly art therapy group. No participants in
the intervention arm received additional group art
therapy.
Randomisation and allocation
Consenting patients were individually randomised and
assigned across both allocations. Statistical support was
provided within the study (TC). Simple randomisation
was used to generate the allocation sequence using a
computer statistical package (IBM SPSS Statistics ver-
sion 25 ©). The concealed sequence was retained by a
research assistant who was independent from the re-
cruitment process at each study site. As blinding to
treatment was not possible in this study, allocation
concealment was maintained for participants following
baseline assessment. Local study therapists and research
staff conducting enrolment were blinded at baseline as-
sessment and then requested the allocation via email con-
tact with the research assistant on a participant by
participant basis. Participants were then informed if they
had been assigned to either interpersonal art psychother-
apy or to usual care delayed treatment. A CONSORT dia-
gram detailing recruitment, allocation, delayed-treatment
and retention is shown in Fig. 1.
Measures
The Modified Overt Aggression Scale (MOAS) [41] is an
observer-rated treatment outcome measure for people
with intellectual disabilities. The MOAS measures both
the frequency and severity of aggressive behaviour (< 10
or > 10 observations) in the previous 7 days. It measures
four types of aggression, namely (a) verbal aggression,
(b) physical aggression against objects, (c) physical ag-
gression against self and (d) physical aggression against
other people. Agreement between raters for MOAS total
scores is high (intra-class correlation coefficient (ICC))
of 0.93, verbal aggression (ICC = 0.90) and physical ag-
gression against others (ICC = 0.90) [41]. The MOAS
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was collected on a weekly basis by research assistants for
the duration of the study, providing extended post-
treatment follow-up data.
The following self-report measures were administered
by research assistants (being blinded to allocation) at
baseline. Assessments were then repeated at post-test
(between 15 and 18 weeks at end of treatment or prior
to the start of delayed treatment) and at 12 weeks post-
treatment follow-up. Research assistants were asked to
report upon participants’ responses to these measures,
for example, the overall burden of assessment and when
participants required additional prompting or explana-
tions for item questions.
The Brief Symptom Inventory (BSI) [42] is a 53-item
self-report inventory with good internal consistency
(Cronbach’s alpha: 0.84), sensitivity of 82%, specificity of
75% and provides information regarding symptom dis-
tress on a range of psychological symptoms. Sub items
can be calculated for a Global Severity Index (GSI),
Positive Symptom Total (PST) and Positive Symptom
Distress Index (PSDI). The BSI was administered to both
arms by research assistants using an ‘assisted completion
format’ [43, 44].
The Novaco Anger Scale (NAS) [45] is a 48-item self-
report questionnaire designed to index a person’s dis-
position for anger (a risk factor for aggression). The
Fig. 1 CONSORT flow diagram
Hackett et al. Pilot and Feasibility Studies           (2020) 6:180 Page 6 of 14
NAS has internal reliability (alpha) of .95 and a 2-week
test-retest reliability of .84. Subscales are included for ‘cog-
nitive’ composed of items operationalising justification,
rumination, hostile attitude and suspicion; ‘arousal’—in-
tensity, duration, somatic tension and irritability; ‘behav-
ioural’—impulsive reaction, verbal aggression, physical
confrontation and indirect expression.
The Glasgow Anxiety Scale for people with intellectual
disability (GAS-ID) [46] is a 27-item self-rating scale of
anxiety-symptoms for people who have a mild intellec-
tual disability. The maximum possible score on this scale
is 54, with subtotals for component scales. Internal
consistency for the GAS-ID total scores is reported to be
0.96, and subscales ‘worries’ 0.92, ‘fears’ 0.80 and
‘physiological symptoms’ 0.90. Test-retest reliability is
reported to be 0.95 [46].
ICEpop CAPability Quality of Life measure for Adults
(ICECAP-A V2) [47, 48] assesses capability (what an in-
dividual can do) rather than functioning (what they actu-
ally do) to avoid imposing a particular idea of what a
good life constitutes and to reflect the importance of
freedom to choose [49]. Components include attach-
ment (an ability to have love, friendship and support),
stability (an ability to feel settled and secure), achieve-
ment (an ability to achieve and progress in life), enjoy-
ment (an ability to experience enjoyment and pleasure)
and autonomy (an ability to be independent). This con-
ceptualisation of wellbeing may fit more appropriately
with accurate assessment of the personal circumstances
of patients detained in secure care. The ICECAP-A was
included within this feasibility study to assess if it could
be used within an intellectual disability population and
included in cost-effectiveness analysis in a future trial.
The ICECAP-A cannot be used to elicit quality adjusted
life tears (QALYs) but has been suggested for the
purpose of economic evaluation focusing on full or suffi-
cient capability [50, 51].
Therapy process observations were completed by study
therapists at the first therapy session and at 3-week in-
tervals following the start of treatment using the Work-
ing Alliance Inventory (WAI-Therapist) [52]. The WAI
is one of the most frequently used instruments in the
therapeutic alliance literature [53] consisting of three
subscales: affective bond, agreement on tasks and agree-
ment on goals. The subscales provide separate scores for
each of the three domains they measure and a global
score of the working alliance. Items are rated on a Likert
scale ranging from 1 (never) to 7 (always) with 2 (rarely),
3 (occasionally), 4 (sometimes), 5 (often) and 6 (very
often) between the two extremes. Various studies of the
Working Alliance Inventory-Observer scale (WAI-O)
[54] have demonstrated high internal consistency (α =
.93) [55], predictive validity and interrater reliability, e.g.
an intraclass correlation coefficient of .92 in [54].
Enrolment
Study information was shared with clinical staff and
MDTs within the secure care settings including letters
to responsible clinicians providing study information
and the inclusion and exclusion criteria. Patients were
provided with study information and if they wished to
participate, they were invited to have a member of staff
‘who knows them well’ present as a witness. Where
needed, patients were read the study information and
consent form [56]. Additional checks [36] were com-
pleted if any concerns were raised regarding a patient’s
capacity to consent by either the patient, their respon-
sible clinician and/or a member of the MDT or a mem-
ber of the local research team. Patients were given a
minimum of 48 h to decide if they would like to partici-
pate after receiving study information. Baseline measures
were administered to consenting patients prior to ran-
domisation allocations being shared.
To assess the feasibility of trial procedures, an email
reporting system to the chief investigator was in place
alongside routine trial meetings with members of the
study team. Routine supervision of therapists delivering
the manualised treatment took place throughout the
study. Individual debriefing sessions with research assis-
tants took place and post-study group interviews were
conducted with all study therapists.
Data analysis
Summary statistics are presented for each outcome
measure separately by arm at each study time point
(baseline and post-test). Summary statistics for the dif-
ference between post-test and baseline time points are
also presented within each trial arm. Magnitudes of dif-
ferences are reported using Cohen’s d, along with corre-
sponding 95% CI [57]. ANOVA was used to explore
small data-sets, for example, the Working Alliance In-
ventory (WAI). Measures of inter-rater reliability were
applied within treatment fidelity checks. Qualitative
thematic analysis of interview data [34] was used for
study therapists responses to the delivering the man-
ualised intervention and to assess SCD participants
perceptions of acceptability of an attentional condi-
tion [32]. In addition, descriptive statistics were ap-
plied to survey data.
Results
RCT demographic information
Table 1 shows baseline demographic information be-
tween groups. All participants were being treated in se-
cure care, ranging from high (20%), medium (55%) and
low (25%) secure hospitals with average length of stay
being 5 years and 9 months, ranging from 11 months to
18 years. The largest ethnic groups in the study were
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White British (60%) and Black British (25%). Most par-
ticipants had a mild intellectual disability (85%).
RCT feasibility objectives
The target for recruitment of 20 participants across
three medium-high secure hospitals was achieved (see
Fig. 1 CONSORT diagram). Members of the clinical
teams across multiple-sites were willing to support re-
cruitment to the study with the exception of patients
who were already actively engaging in psychological
therapies in their clinical treatment (n = 5). Similarly, pa-
tients included in a therapeutic community programme in
one secure hospital were not permitted to take part in in-
dividual psychological therapies in addition to their group
based treatment programme (n = 10). A total of ten pa-
tients declined to participate with some stating that they
did not want to interrupt their current timetable of activ-
ities. Study information was suitable for the patient group.
Procedures for gaining consent were carried out with no
changes to the published protocol [26].
All participants allocated to interpersonal art psycho-
therapy completed their treatment (n = 10). Combined
completion rates for participants who started interper-
sonal art psychotherapy (including those having delayed
treatment) was 94% (17/18) with one participant in high
secure hospital being withdrawn from treatment due to
having restricted access to pens and pencils. At post-
test, participant retention across both arms was 90%
Table 1 Baseline demographic comparison between groups and single-cases
IAP (n = 10)
Mean (SD) or count
Waitlist (n = 10)
Mean (SD) or count
Single-case Design (n = 4)
Years, months, or count
Gender Men 8 10 4
Women 2 – –
Age (years) 33.2 (10) 31.4 (7.5) 20,22,23,23
Secure care High 2 2 –
Medium 5 6 3
Low 3 2 1
Time in hospital (months) 63 (46) 79 (72) 5,9,33,34
Ethnicity White British 6 6 3
White Irish – – 1
Black British 4 1 –
British Indian – 1 –
Black African – 1 –
Black Caribbean – 1 –
Intellectual disability Borderline intellectual functioning – – –
Mild 8 9 2
Moderate 2 1 –
Additional diagnosis Schizophrenia/paranoid schizophrenia 1 5 –
Antisocial personality disorder 1 – –
Alcohol dependence syndrome 1 – –
Autistic spectrum disorder 2 – 1
Attention-deficit hyperactivity/kinetic disorder 1 – 1
Head injury – 1 –
Sensory neural deafness – 1 –
None 4 3 2
Criminal/index offence Sexual offence/assault 4 2 2
Physical assault/affray 3 3 1
Criminal damage 1 1 –
Arson 1 2 –
Theft/burglary – 2 1
Murder 1 – –
IAP interpersonal art psychotherapy
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(18/20). High completion rates for the MOAS [41] ob-
servational measure led to 100% (20/20) of the target
primary outcome data being collected and analysed at
post-test and 85% (17/20) at follow-up (for both arms).
Participants on the waiting-list had a 20% (2/10) drop-
out rate prior to starting their delayed treatment. Partici-
pant drop-out from the delayed treatment group was re-
ported as being primarily due to deteriorating mental
health. Participants allocated to fifteen sessions of inter-
personal art psychotherapy were required to remain in
the study for approximately 8 months, with a 20% (2/10)
loss to follow-up for secondary outcome repeated mea-
sures. Participants who were allocated to the usual care,
received delayed interpersonal art psychotherapy and
assessed at follow-up 3-month post-treatment were re-
quired to remain in the study for up to 12 months.
Maintaining full data-collection integrity across multiple-
sites was not fully achieved due to procedures not being
carried out correctly at one site (secondary outcome mea-
sures were not collected at baseline from two participants
in the delayed treatment arm). Due to limited resources in
this study, capacity for live data-collection monitoring was
not possible. Four participants declined to complete sec-
ondary outcome measures at follow-up assessment.
Observations of burden of assessment were reported
by research assistants. Administration of the BSI was
conducted using an assisted completion format [43] with
some participants needing more than one meeting with
the research assistant to complete all items. Participants
were found to have no difficulty with completion of the
GAS-ID and NAS. Research assistants administering the
tests reported that some participants struggled to under-
stand some items of the ICECAP-A assessment, which
were abstract in concept and required further explanation.
Treatment fidelity
Assessment procedures for treatment fidelity and man-
ual adherence were completed using the interpersonal
art psychotherapy checklist, with therapists having been
instructed to audio record all treatment sessions during
the study. The treatment fidelity assessment was con-
ducted from 27 randomly selected recordings (8 early,
11 middle, 8 late therapy). Study therapists were assessed
as having 82% adherence to the interpersonal art psy-
chotherapy manual.
Study therapist group interviews
Two post-study group interviews were carried out with
all study therapists. Interview schedules focused on their
experiences of intervention delivery [58] and questions
were informed by an implementation science approach
[59]. Qualitative thematic analysis [34] of transcriptions
from the group discussion were completed.
The therapists’ responses to treatment fidelity proce-
dures and manual adherence checks indicated that ther-
apists gained confidence during the study in following
the treatment manual instructions. Therapists reported
that the recording of therapy sessions for treatment
fidelity checks within a secure hospital context raised
concerns for some participants, who associated audio-
recording devices with the experience of police inter-
views and required additional reassurance.
Preliminary ‘signal’ of the efficacy of the intervention
Effect-size estimates (Cohen’s d) for baseline-post-test
difference between groups are shown in Table 2. Be-
tween group differences at post-test comparison of the
interpersonal art psychotherapy versus the delayed treat-
ment control showed an effect-size of .65 (− 0.25–1.54,
95% CI) for total scores and .93 (0.01–1.85, 95%CI) in
the verbal aggression sub-scale. The Brief Symptom In-
ventory–Positive Symptom Distress Index (BSI-PSDI)
showed a between group effect-size of .79 (− 0.20–1.79,
95% CI).
Pooled MOAS data from all interpersonal art psycho-
therapy completers (n = 17) (combined scores from both
arms including delayed treatment participants) can be
seen in Fig. 2. Mean MOAS scores showed a reduction
from baseline M = 6.1 (SD = 8–1) to post-test M = 2.4
(SD = 5.4), and follow-up M = 1.4 (SD = 3.5).
For seven patients, the Working Alliance Inventory
(WAI) ratings were completed for five of the timepoints;
for the other 11 patients, the data were incomplete.
Based on the available data, the repeated measure
ANOVA indicated a positive change in working alliance
over treatment, F = 2.976 (4), p = .036. Overall, within
this small sample, alliance was not significantly related
to any of the outcome measurements. Participants with
more severe psychopathology (as measured on the BSI-
GSI) had a lower working alliance throughout the treat-
ment than the other participants.
Indicative sample size calculation
For the MOAS primary outcome measure, we conducted
a sample size calculation assuming power of 90% and a
type I error rate of 5%. Based on the results of the feasi-
bility study, we also assumed it would be important to
detect a clinically important difference of 5 points on
the MOAS scale and we assumed a common SD in the
control and intervention groups of 10 points. In
addition, to account for the fact that a single therapist
would apply the intervention to more than one partici-
pant, we made the following assumptions to account for
this type of clustering. It was assumed that in a future
trial, each site would have a minimum of 2 therapists
and the intraclass correlation (ICC) of the MOAS scores
for the same therapist would be 1%. This is consistent
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with assumptions used in similar studies. Using these as-
sumptions as a basis, we calculated that 96 participants
would be required in each group. Allowing for an as-
sumed attrition rate of 20%, the study would require 120
participants in each group or a total of 240 participants.
This would also allow the study to detect a difference
of 0.5 points on the change in BSI-positive symptom dis-
tress index to be detected as a secondary outcome, using
a SD estimate of 0.8. Based on the sample size calculated
above, this would result in a power in excess of 90% for
the BSI comparison.
Attentional condition acceptability (single-case design)
For the assessment of the acceptability of an attentional
control condition (art and craft activity/active psycho-
logical comparator), participants (n = 4) were offered up
to 15 sessions (up to 1 h) of mindful colouring-in [30,
60, 61] facilitated by a qualified art psychotherapist. A
convenience sample (non-randomised) of four patients
from a secure NHS hospital (Northumberland) with
medium-low secure wards, see demographic information
in Table 1. SCD participants were recruited within 3
months of the study opening. This component took part
between February 2017 and February 2018.
Mindful colouring-in (pilot attentional condition)
This treatment involved providing basic verbal and writ-
ten instructions about mindfulness, offering a selection
of ‘art therapy’ colouring-in books (frequently available
to buy in bookshops in the UK), and introducing guided
mindfulness and relaxation techniques. Sessions were
Table 2 Descriptive statistics for baseline and post-test difference and effect size estimates
M mean, SD standard deviation, Mdn median, IQR interquartile range, MDiff mean difference, No number, ES effect size estimate, SE standard error, CI confidence
interval, MOAS Modified Overt Aggression Scale, BSI Brief Symptom Inventory, NAS Novaco Anger Scale, GAS Glasgow Anxiety Scale, ICECAP-A ICEpop CAPability
measure for Adults, Effect Size CC 95% (dCohen calculation according to Hedges & Olkin, 1985, p. 86)
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conducted on a one-to-one basis in a private room in
the secure care unit.
To assess similarities and differences between mindful
colouring-in and interpersonal art psychotherapy, audio
recordings of mindful colouring-in sessions were rated
against the interpersonal art psychotherapy checklist. In
comparison to interpersonal art psychotherapy, partici-
pants in mindful colouring-in sessions spent more time
(proportionately) on art activities, sessions were ‘mindful-
ness-oriented’ with therapists directing participants
accordingly (i.e. awareness of breathing), therapist-client
verbal interactions occurred primarily before and after
the colouring and/or relaxation activity and time spent in
conversation with the therapist was significantly shorter
in duration than in interpersonal art psychotherapy.
Attentional condition acceptability assessment
The acceptability of mindful colouring-in was assessed
using multiple SCD studies (n = 4) to inform RCT design
where an attentional condition [27, 29] might be included
as a third arm. Participants (n = 4) completed between 10
and 14 individual mindful colouring-in sessions and were
then invited to take part in one-to-one semi-structured
audio-recorded interviews. A thematic analysis [34] was
carried out on interview transcriptions and matched
against a conceptual treatment acceptability framework
[32]. This mapping exercise identified that mindful
colouring-in matched against six out of seven of the treat-
ment acceptability criteria, including (a) affective attitude,
with participants giving generally positive feedback about
the intervention; (b) burden, an acceptable amount of
effort was required to participate; (c) ethicality, the inter-
vention was seen as a fitting activity with participants
reporting feelings of control over session time and their
level of participation in the sessions; (d) intervention
coherence and (e) perceived effectiveness, participants
reported understanding the intervention and gave
personal examples of how it worked for them, i.e. ‘distrac-
tion’, ‘relaxation’ and ‘reducing angry feelings/agitation’; (f)
self-efficacy, with participants reporting having confidence
in performing tasks inside and outside of the sessions; and
no themes could be matched to (g) opportunity costs, for
example, comments were not made by participants relat-
ing to the extent to which they felt that any benefits or
values must be given up in order to engage with the inter-
vention [32].
Trial capacity (survey)
The aim of the survey was to identify the capacity for
qualified art psychotherapists working in secure care set-
tings in the UK to take part in a future trial. The survey
was disseminated via the British Association of Art
Therapists (BAAT) (2426 members), including the Art
Therapy and Learning Disability Special-Interest Group
(ATLDSIG) (88 members), and the Forensic Arts Ther-
apies Advisory Group (FATAG) (468 members inclusive
of art, dance movement, drama and music therapists)
with a closing date in January 2018.
From the 27 survey respondents, 26 met the criteria of
being UK Health and Care Professions Council (HCPC)
registered art psychotherapists; 62% (16/26) worked in
NHS Secure Care, 27% (7/26) Prison Service, 11% (3/26)
Private/other secure care providers. There was no duplica-
tion of respondents from the same institution. A total of
88% (23/26) of therapist were willing to take part in a fu-
ture art psychotherapy research study with 84% (22/26)
willing to follow a structured treatment manual (i.e. inter-
personal art psychotherapy) if trained to do so. Art psy-
chotherapists who indicated that they would be willing to
participate in a future trial using a manualised treatment
Fig. 2 Mean MOAS scores for groups and interpersonal art psychotherapy completers (combined data).
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(n = 22) routinely provided between 3 and 20 individual
art psychotherapy sessions per week (Mdn = 7.5, IQR = 7)
often in addition to their work providing group based
treatment. Willing respondents estimated that up to 1051
(Min/Max 6–180, Mdn = 22, IQR = 70) patients/prisoners
within the secure care settings they worked in would meet
minimum eligibility requirements for accessing art
psychotherapy as a treatment. From this, total 341
patients/prisoners were estimated as having either low in-
tellectual functioning or an intellectual disability.
Discussion
The purpose of this study was to assess the feasibility of
conducting an RCT of interpersonal art psychotherapy
with adults who have an intellectual disability in secure
care. Study procedures enabling recruitment and reten-
tion at follow-up appear to be viable within secure care
settings. The target of recruiting 20 participants to the
trial from multiple sites was achieved within 8 months
of the study opening. There were no substantive amend-
ments to the published protocol. In a future trial, adjust-
ment is required to our systems for live data-collection
monitoring which could be rectified though greater re-
sources being available to the research team.
We believe that the present protocol could be scaled-
up to a fully-powered randomised controlled trial.
Change estimates themselves do not form part of the
decision to move to a definitive trial but are merely pre-
sented for information. Given the imprecisions that re-
sults from small feasibility samples [62], we have taken a
cautious approach. Our calculation of sample size is
based upon minimum important clinical difference, this
being a clinical judgement and not taken as the differ-
ence observed in any feasibility work.
Importantly, ethical considerations did not emerge
during the study with patients detained under the Men-
tal Health Act [35] feeling free to decline their participa-
tion in the study with no indication of any confusion or
coercion. Data collection for the MOAS achieved a high
rate of completion, feasible to use as a primary outcome
measure. In a future trial, the MOAS could be used as a
screening assessment during enrolment with a lower
threshold score being set for eligibility in order to ex-
clude patients with no observed aggressive behaviours.
Our observations of participants completing the ICECAP-
A indicated that further work is needed to consider the
support people with intellectual disabilities might need to
complete it. With suitable adaptations to this measure, it
is possible that future within-trial cost-effectiveness ana-
lysis could be conducted [63]; for example, focusing on
the incremental costs of providing art psychotherapy rela-
tive to usual care.
Treatment fidelity checks showed study therapists as
achieving 82% adherence to the interpersonal art
psychotherapy manual and a preliminary assessment of
therapeutic alliance indicated measurable gains within
early sessions.
From both arms, including delayed treatment, partici-
pants who started interpersonal art psychotherapy
achieved a high completion rate of 94% (17/18). We re-
cruited a number of participants in the study (30%) who
had a dual diagnosis of intellectual disability and schizo-
phrenia or paranoid schizophrenia, schizophrenia being
identified a factor associated with higher rates of in-
patient violence [5]. Participants with an additional diag-
nosis such as autistic spectrum disorder completed
treatment and engaged in the structured approach to
manualised session delivery.
Whilst this study was not statistically powered to de-
tect between group differences, we believe that a ‘signal’
for the potential of interpersonal art psychotherapy was
indicated in our post-test comparison with the delayed
treatment control. This is shown in a between group
effect-size of .62 for total MOAS scores and .93 in the
verbal aggression sub-scale, with improvements in
reduced verbal aggression potentially indicating the suc-
cessful targeting of ‘interpersonal’ antecedents of phys-
ical aggression. Participants distress related to their
mental health symptoms, as measured by the BSI-PSDI
showed a between group effect-size of .79. We believe
that these signals from the data indicate potential merit
in interpersonal art psychotherapy for the reduction of
aggressive behaviour and improvements in patient’s self-
reported distress [64].
A national survey conducted across secure care
provision in the UK indicated that there is both willing-
ness and capacity amongst suitably qualified and regis-
tered art psychotherapists to support a future trial.
Conclusions
This protocol, with modifications to screening proce-
dures and data collection procedures, can be extended
to a fully powered trial. Recruitment and retention rates
were shown to be acceptable. Interpersonal art psycho-
therapy was found to bring about improvements in ob-
served aggression and distress related to mental health
symptoms in adults with intellectual disability in secure
care. Positive engagement in interpersonal art psycho-
therapy from patients with an additional diagnosis of
schizophrenia are promising, particularly as this is a
factor associated with higher levels of aggression in in-
patient care [5]. Observations of reduced verbal aggres-
sion in the treatment group may also provide some
indication that interpersonal factors associated with ag-
gression were suitably targeted in the intervention. Based
upon the present design, a fully powered study is recom-
mended to assess the effectiveness of interpersonal art
psychotherapy.
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